FDA: Stronger warnings for Propulsid
March 1st 2000The Food and Drug Administration is warning patients taking Titusville, NJ-based Janssen Pharmaceutica's heartburn treatment, Propulsid® (cisapride) of new advisories concerning the drug. Propulsid is a treatment for severe nighttime heartburn in patients with gastroesophagal reflux disease who do not adequately respond to other therapies. The new measures are being recommended to help physicians avoid giving Propulsid to patients who are at known risk of rare, but serious, cardiac events associated with the drug.
IOM releases report on medical errors
February 1st 2000A new report on medical errors from the National Institutes of Medicine of the National Academies calls for changes throughout the healthcare system including mandatory reporting requirements. The report, titled "To Err is Human: Building a Safer Health System," lays out a comprehensive strategy for government, industry, consumers and healthcare providers to reduce medical errors.
AMA sues HHS secretary for failure to correct errors
February 1st 2000The American Medical Association, Chicago, filed a federal lawsuit on Dec. 2, 1999, charging Donna E. Shalala, secretary of the U.S. Department of Health and Human Services, with failure to exert her authority and correct errors in the system used by Medicare to pay physicians for care provided to the nation's elderly.